| Product Name | MF | CAS | Details |
|---|
| 3-(2-Fluorophenyl)-3-oxopropionitrile | C9H6FNO | 31915-26-1 | Details |
| 5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile | C16H12N4O | 330792-70-6 | Details |
| 2-Ethyl Milrinone | C13H11N3O | 78504-63-9 | Details |
| 1,3-Diazepane-2,4,6-trione | C5H6N2O3 | 338756-68-6 | Details |
| 4-ethoxy-3-(4-pyridyl)-3-buten-2-one | C11H13NO2 | 88349-61-5 | Details |
| 1-METHYLHYDANTOIN | C4H6N2O2 | 616-04-6 | Details |
| 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-[2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]-, ethyl ester, (4R,5S)-rel- | C22H32N2O6 | 2434599-55-8 | Details |
| Creatine | C4H9N3O2 | 57-00-1 | Details |
| 1-Piperazinecarboxaldehyde, 4-[2-[(2,4-dimethylphenyl)sulfinyl]phenyl]- | C19H22N2O2S | 2425618-48-8 | Details |
| Dibanzyloxy phosphatecreatinine | C18H20N3O4P | 19208-69-6 | Details |
| Cyanamide, N,N-dicyano- | C3N4 | 97904-31-9 | Details |
| Cetirizine IMpurity D | C30H28Cl2N2 | 346451-15-8 | Details |
| Cetirizine EP Impurity B Ethyl Ester | C21H25ClN2O2 | 19178-83-7 | Details |
| 2-(4-((4-chlorophenyl)(phenyl)methyl) piperazin-1-yl)acetic acid dihydrochloride | C19H21ClN2O2 | 113740-61-7 | Details |
| Cetirizine Impurity 40 | C24H31ClN2O4 | 2705552-48-1 | Details |
| 4-(DIPHENYLMETHYL)-1-PIPERAZINEETHANOL DIHYDROCHLORIDE | C19H26Cl2N2O | 108983-83-1 | Details |
| Prasugrel EP Impurity E | C20H21ClFNO3S | 1056459-37-0 | Details |
| 1-benzhydrylpiperazine dihydrochloride | C17H22Cl2N2 | 66090-75-3 | Details |
| Prasugrel Impurity 13 HCl | C18H19ClFNOS | 1618108-01-2 | Details |
| N-[3-Fluoro-4-[(MethylaMino)carbonyl]phenyl]-2-Methylalanine | C12H15FN2O3 | 1289942-66-0 | Details |
| Methyl 2-fluoro-4-((1-methoxy-2-methyl-1-oxopropan-2-yl)amino)benzoate | C13H16FNO4 | 1802242-47-2 | Details |
| N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine methyl ester | C13H17FN2O3 | 1332524-01-2 | Details |
| Enzalutamide Impurity12 | C21H15F4N3O3S | 1802242-43-8 | Details |
| 2-(Methoxy(4-phenoxyphenyl)Methylene)Malononitrile | C17H12N2O2 | 330792-69-3 | Details |
| AcotiaMide | C21H30N4O5S | 185106-16-5 | Details |
| 4-Thiazolecarboxamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2,4,5-trimethoxybenzoyl)amino]-, hydrochloride (1:1) | C22H33ClN4O5S | 1349810-29-2 | Details |
| 2-(Hydroxy(4-phenoxyphenyl)methylene)malononitrile | C16H10N2O2 | 330792-68-2 | Details |
| Omeprazole Impurity 1 | C16H17N3O2S | 103877-02-7 | Details |
| 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl}-1H-benzimidazole | C17H18N3O4ST | 1810066-05-7 | Details |
| Acotiamide Hydrochloride impurity K | C18H24N4O5S | 701197-05-9 | Details |
| 4,5''-Di(desmethyl) Omeprazole Sulfide | C15H15N3O2S | 176219-12-8 | Details |
| Acotiamide impurity C | C17H28N2O4 | 1824734-16-8 | Details |
| Argatroban Impurity 6 | C10H8ClNO2S | 94975-84-5 | Details |
| N2-(tert-Butoxycarbonyl)-Nw-nitro-D-arginine | C11H21N5O6 | 50913-12-7 | Details |
| Glycine,N-(aminoiminomethyl)-N-methyl-, ethyl ester | C6H13N3O2 | 15366-29-7 | Details |
| trans-4-(6,8-Dibromoquinazolin-3(4H)-yl)cyclohexanol Hydrochloride | C14H17Br2ClN2O | 2356152-56-0 | Details |
| 1H-Imidazole, 1-[2-(ethylsulfinyl)ethyl]-2-methyl-5-nitro- | C8H13N3O3S | 2376335-05-4 | Details |
| Ethyl2-oxo-2-(pyridin-2-ylamino)acetate(EdoxabanImpurity) | C9H10N2O3 | 41374-72-5 | Details |
| Trelagliptin Impurity | C14H12FN3O3 | 2088203-83-0 | Details |
| 1-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-ethanone | C15H21N5O | 344418-61-7 | Details |
| Parecoxib Impurity | C17H15NO4S | 2749361-92-8 | Details |
| 1-Boc-4-(6-nitropyridin-3-yl)piperazine | C14H20N4O4 | 571189-16-7 | Details |
| Pyrido[3,2-d]pyrimidin-6(5H)-one, 5-cyclopentyl-8-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]- | C22H27N7O | 2745066-17-3 | Details |
| Trelagliptin Impurity 5 | C13H16FN3 | 1971613-57-6 | Details |
| Benzonitrile, 2-[[6-[(3R)-3-[[(2-cyano-5-fluorophenyl)methyl]amino]-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluoro- | C26H24F2N6O2 | 2412663-46-6 | Details |
| Clopidogrel Impurity | C21H23Cl2NO2S2 | 2173294-67-0 | Details |
| Benzeneacetic acid, α-amino-2-chloro-, ethyl ester, hydrochloride (1:1), (αS)- | C10H13Cl2NO2 | 2649375-64-2 | Details |
| Febuxostat Impurity 61 | C9H10O2S | 168780-80-1 | Details |
| Clopidogrel Bisulphate | C16H16ClNO2S.H2O4S | 2637140-93-1 | Details |
| Methyl 2-(2-chlorophenyl)-2-oxoacetate | C9H7ClO3 | 34966-49-9 | Details |
| 5-Thiazolecarboxylic acid, 2-(4-hydroxy-3-methylphenyl)-4-methyl-, ethyl ester | C14H15NO3S | 1621995-80-9 | Details |
| METHYL AMINO(3-CHLOROPHENYL)ACETATE HYDROCHLORIDE | C9H11Cl2NO2 | 1351586-91-8 | Details |
| Clopidogrel EP Impurity F | C15H16ClNO2S | 141109-20-8 | Details |
| 1-(4-CHLOROPHENYL)-2-METHOXY-2-OXO-1-ETHANAMINIUM CHLORIDE | C9H11Cl2NO2 | 42718-19-4 | Details |
| 2-amino-2-(2-chlorophenyl)acetamide | C15H14ClNO2S | 1198220-10-8 | Details |
| 2-(2-Methylthiazol-5-yl)acetic acid | C6H7NO2S | 52454-65-6 | Details |
| (S)-2-(2-Chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)aceticacid(ClopidogrelImpurity) | C14H14ClNO2S | 1015247-87-6 | Details |
| Benzenepropanoic acid, 4-fluoro-b-oxo- | C9H7FO3 | 80646-00-0 | Details |
| 1-Piperazinecarboxaldehyde, 4-ethyl- | C7H14N2O | 21863-75-2 | Details |
| 3-(4-fluorophenyl)-3-oxopropanamide | C9H8FNO2 | 671188-82-2 | Details |
| 1,3-Benzenedicarbonitrile, 4-ethoxy- | C10H8N2O | 161718-82-7 | Details |
| ethyl 2-(5-cyano-2-isobutoxyphenyl)-4-methylthiazole-5- carboxylate | C11H10N2O | 1229019-33-3 | Details |
| Febuxostat Impurity 33 | C12H14O5 | 100118-38-5 | Details |
| Febuxostat Impurity Z10 | C11H13NO | 5203-15-6 | Details |
| Febuxostat Impurity 19 | C22H24N2O5S2 | 1330632-47-7 | Details |
| Febuxostat Impurity 27 | C21H15N3O3 | 7753-13-1 | Details |
| Febuxostat Impurity 70 | C16H16N2O3S | 2418591-43-0 | Details |
| 5-Thiazolecarboxylic acid, 2-[3-carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-, 5-methyl ester | C17H19NO5S | 2476465-39-9 | Details |
| ethyl 2-(2-(4-hydroxyphenyl)thiazol-4-yl)acetate | C13H13NO3S | 886503-50-0 | Details |
| ethyl 2-(3-formyl-2-isobutoxyphenyl)-4-methylthiazole-5- carboxylate | C12H12N2O | 1805770-41-5 | Details |
| FeBuxostat Impurity 26 | C14H12N2O3S | 1886961-39-2 | Details |
| Febuxostat Impurity 40 | C7H7NOS | 7133-90-6 | Details |
| Ticagrelor Impurity 117 | C7H12ClN3O2S | 1549834-66-3 | Details |
| Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, ethyl ester | C17H18ClNO2S | 90055-81-5 | Details |
| Ticagrelor Impurity 155 | C7H9Cl2N3O2S | 1482484-62-7 | Details |
| Ticagrelor Impurity 208 | C16H17ClF2N4S | 2368940-71-8 | Details |
| Ticagrelor Related Compound I | C10H19NO4 | 2165881-71-8 | Details |
| 2-(((3aR,4S,6R,6aS)-6-(7-chloro-5-(propylthio)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH- cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | C17H24ClN5O4S | 1423768-39-1 | Details |
| Ticagrelor Impurity 4 | C12H18N6O3S | 1395048-17-5 | Details |
| Ticagrelor Related Compound 85 | C28H34F2N6O5S | 1628340-74-8 | Details |
| Thieno[3,2-c]pyridinium, 5-[(2-chlorophenyl)methyl]-6,7-dihydro-, bromide (1:1) | C14H13BrClNS | 2418591-13-4 | Details |
| Ticagrelor Impurity 89 | C14H23NO9 | 1402149-98-7 | Details |
| 1-(2-chlorophenyl)-2-ethoxyethanamine | C10H14ClNO | 1485619-90-6 | Details |
| Ticagrelor Imp.H | C14H22N6O4S | 2309231-60-3 | Details |
| 2,4(1H,3H)-Pyrimidinedione, 6-amino-3-ethyl- | C6H9N3O2 | 21237-00-3 | Details |
| 2,4(1H,3H)-Pyrimidinedione, 6-amino-1,3-diethyl-5-nitro- | C8H12N4O4 | 146946-10-3 | Details |
| Ticagrelor Impurity H | C25H30F2N6O5S | 1402150-10-0 | Details |
| Ticagrelor Impurity 3 | C17H27ClN4O5S | 2197189-31-2 | Details |
| INDEX NAME NOT YET ASSIGNED | C18H24ClN7O4S2 | 2681352-85-0 | Details |
| Ticagrelor intermediate 12 | C17H27ClN4O4S | 1423768-38-0 | Details |
| Ticagrelor Impurity 12 | C9H10FN | 220349-80-4 | Details |
| Ethanol, 2-[[(3aR,4S,6R,6aS)-tetrahydro-6-[7-methoxy-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- | C18H27N5O5S | 1431867-57-0 | Details |
| 4-Methylcinnamic acid | C12H14O2 | 24393-49-5 | Details |
| Ozagrel Impurity 37 | C12H14O3 | 530145-11-0 | Details |
| 4-Fluorobenzoylacetonitrile | C9H6FNO | 4640-67-9 | Details |
| 3-AMINO-3-(4-BROMOPHENYL)ACRYLONITRILE | C9H7BrN2 | 748807-82-1 | Details |
| 4-Chlorobenzoylacetonitrile | C9H6ClNO | 4640-66-8 | Details |
| 3-Amino-3-(4-chlorophenyl)prop-2-enenitrile | C9H7ClN2 | 107840-43-7 | Details |
| (Z)-3-Amino-3-(4-fluoro-phenyl)-acrylonitrile | C9H7FN2 | 55330-46-6 | Details |
| Product Total： Product Page： | ||||
| 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 | ||||